Characterization of a new glioblastoma cell line, GB-val4, with unusual TP53 mutation.

Human Cell
Lisandra Muñoz-HidalgoConcha López-Ginés

Abstract

A novel cell line derived from a human glioblastoma (GB), named GB-val4, has been established and characterized. GB-val4 cells were hyperdiploid, with many numerical and structural chromosomal rearrangements. The cell line did not show mutations in IDH1/IDH2 genes or EGFR amplification, but it presented two missense mutations in TP53, which imply a very low p53 protein activity within the cell line. Cells also had gain of TP73 copies, hypermethylation of APC, CASP8 and RASSF1, increased expression of ARF1, CDH1 and NF-κB and decreased expression of CDKN2A. Tumorigenity was demonstrated by transplant of GB-val4 cells into athymic nude mice, where solid tumors were grown. Interestingly, a high percentage of GB-val4 cells presented expression of GSC markers CD133 or CD44. These GSC markers were increased in neurosphere cultures, which better mimic solid tumor conditions and maintain the genetic features of the tumor cells. In this study, we aimed to define the characteristics of this novel cell line and its applications in human cancer research. With its genetic features and a poor p53 activity, GB-val4 cells resemble GB tumors. Moreover, the important presence of GSCs in adherent cultures and especially in neurosphere cultures ma...Continue Reading

References

Jun 17, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Rosario Gil-BensoAntonio Llombart-Bosch
Jun 28, 2005·Journal of Neuropathology and Experimental Neurology·Hiroko Ohgaki, Paul Kleihues
Jan 7, 2010·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Rafael BenitoConcha Lopez-Gines
Feb 26, 2010·Cold Spring Harbor Perspectives in Biology·Magali OlivierPierre Hainaut
Oct 15, 2010·Integrative Biology : Quantitative Biosciences From Nano to Macro·Tianhai TianAngus Harding
Jan 20, 2012·Nature·Mel Greaves, Carlo C Maley
Aug 6, 2013·Genes, Chromosomes & Cancer·Beatriz SoldevillaGemma Domínguez
Oct 25, 2013·Current Opinion in Neurology·Kenneth YanJeremy N Rich
Jan 23, 2014·Molecular BioSystems·Prudence DonovanAngus Harding
Mar 22, 2014·Cancer Cell·Patricia A J Muller, Karen H Vousden
Sep 19, 2014·Science Translational Medicine·Suzanne CarreiraGerhardt Attard
Mar 31, 2015·Cancers·Meena Jhanwar-UniyalRaj Murali
Jul 6, 2017·Cytotechnology·Rosario Gil-BensoMiguel Cerdá-Nicolás

❮ Previous
Next ❯

Methods Mentioned

BETA
chromosomal aberrations
PCR
reverse transcription-PCR
xenograft
flow cytometry
Fluorescence

Software Mentioned

FACSDiva
Coffalyser
FlowJo

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.